Celltrion Wins Brazilian Trastuzumab and Rituximab Tender

As Company Aims to Lead Latin American Biosimilar Market

Brazil
Celltrion has won the Brazilian contract for anticancer therapeutics for the second year in a row • Source: Alamy (Alamy Stock Photo)

More from Biosimilars

More from Products